Cabaletta Bio, Inc.
NasdaqGS:CABA
Sector
Location
Market Cap
USD 140.31 M
Share Price
USD 1.56
Avg Daily Volume
2,172,272
Change (1 day)
-0.64%
Change (1 year)
-77.55%
Change (YTD)
-31.28%
Cabaletta Bio, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2024: USD -88.22 M
Cabaletta Bio, Inc. Operating Cash Flow is USD -88.22 M for the Trailing 12 Months (TTM) ending December 31, 2024, a 64.75% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Cabaletta Bio, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -53.55 M, a 15.46% change year over year.
-
Cabaletta Bio, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -46.38 M, a 35.98% change year over year.
-
Cabaletta Bio, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2021 was USD -34.11 M, a 27.42% change year over year.
-
Cabaletta Bio, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2020 was USD -26.77 M, a 66.84% change year over year.
StockViz
Competitors
Biomea Fusion, Inc.
USD 1.66
BMEA
+0.01
0.61%
Black Diamond Therapeutics, Inc.
USD 2.82
BDTX
+0.04
1.44%
Akero Therapeutics, Inc.
USD 47.72
AKRO
+0.23
0.48%
Stoke Therapeutics, Inc.
USD 12.87
STOK
+0.37
2.96%
Gossamer Bio, Inc.
USD 2.08
GOSS
+0.12
6.12%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|